SETD2 Antikörper
-
- Target Alle SETD2 Antikörper anzeigen
- SETD2 (SET Domain Containing 2 (SETD2))
-
Reaktivität
- Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SETD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human SETD2
- Isotyp
- IgG
- Top Product
- Discover our top product SETD2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:200 - 1:500
- Kommentare
-
Ubiquitously expressed
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20C. Avoid freeze / thaw cycles.
-
- Target
- SETD2 (SET Domain Containing 2 (SETD2))
- Andere Bezeichnung
- SETD2 (SETD2 Produkte)
- Synonyme
- Kif9 antikoerper, HBP231 antikoerper, HIF-1 antikoerper, HIP-1 antikoerper, HYPB antikoerper, KMT3A antikoerper, SET2 antikoerper, p231HBP antikoerper, SET domain containing 2 antikoerper, Setd2 antikoerper, SETD2 antikoerper
- Hintergrund
- Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II.
- Molekulargewicht
- 287.597 kDa
- Gen-ID
- 29072
- UniProt
- Q9BYW2
- Pathways
- Tube Formation
-